Palomar (NASDAQ:PLMR) Upgraded at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of Palomar (NASDAQ:PLMR – Free Report) from a neutral rating to an overweight rating in a research report sent to investors on Tuesday morning, Marketbeat Ratings reports. The brokerage currently has $150.00 target price on the stock, up from their prior target price of $115.00. PLMR has been the […]
More Stories
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...
Golden State Wealth Management LLC Acquires 4,508 Shares of CSX Corporation (NASDAQ:CSX)
Golden State Wealth Management LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 123.1% in...
Golden State Wealth Management LLC Grows Stake in Meta Platforms, Inc. (NASDAQ:META)
Golden State Wealth Management LLC grew its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 151.1% during the...
Golden State Wealth Management LLC Has $319,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Golden State Wealth Management LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 623.1% during the...